Shelley B. Thunen - 14 Apr 2025 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Co-President and Chief Financial Officer
Signature
/s/ Shelley Thunen
Issuer symbol
RXST
Transactions as of
14 Apr 2025
Net transactions value
+$33,806
Form type
4
Filing time
15 Apr 2025, 20:57:36 UTC
Previous filing
27 Feb 2025
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Options Exercise $33,806 +7,792 +25% $4.34 38,354 14 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Stock Option (right to buy) Options Exercise $0 -6,405 -100% $0.000000 0 14 Apr 2025 Common Stock 6,405 $4.34 Direct F2
transaction RXST Stock Option (right to buy) Options Exercise $0 -1,387 -100% $0.000000 0 14 Apr 2025 Common Stock 1,387 $4.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 119 shares of Common Stock acquired October 31, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.

Remarks:

Co-President and Chief Financial Officer